Camurus AB (publ) (STO: CAMX)
Sweden
· Delayed Price · Currency is SEK
575.00
+7.00 (1.23%)
Jan 21, 2025, 11:01 AM CET
Camurus AB Revenue
Camurus AB had revenue of 479.60M SEK in the quarter ending September 30, 2024, with 24.90% growth. This brings the company's revenue in the last twelve months to 1.69B, up 4.89% year-over-year. In the year 2023, Camurus AB had annual revenue of 1.72B with 79.52% growth.
Revenue (ttm)
1.69B
Revenue Growth
+4.89%
P/S Ratio
19.25
Revenue / Employee
7.51M
Employees
213
Market Cap
33.40B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.72B | 760.51M | 79.52% |
Dec 31, 2022 | 956.34M | 355.77M | 59.24% |
Dec 31, 2021 | 600.57M | 264.57M | 78.74% |
Dec 31, 2020 | 336.00M | 230.39M | 218.16% |
Dec 31, 2019 | 105.61M | 56.28M | 114.12% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 25.44B |
Getinge AB | 33.59B |
Sectra AB | 3.14B |
Medicover AB | 22.60B |
Vitrolife AB | 3.56B |
Bonesupport Holding AB | 814.46M |
Elekta AB | 17.72B |
Vimian Group AB | 3.99B |
Camurus AB News
- 2 months ago - Camurus AB (CAMRF) Q3 2024 Earnings Call Highlights: Record Profit and Revenue Growth Amid ... - GuruFocus
- 2 months ago - Q3 2024 Camurus AB Earnings Call Transcript - GuruFocus
- 3 months ago - US FDA declines to approve Camurus' rare hormone disorder drug - Reuters
- 7 months ago - New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl - PRNewsWire